secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cingulate Inc. (CING)
CIK:        0001862150
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001493152-23-044970
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cingulate CFO & GC resign; pauses CTx-1301 trial; CEO salary cut 55%; warns of capital need
--------------------------------------------------------------------------------

- CFO Louis Van Horn retired Dec 13; General Counsel Craig Gilgallon resigned effective Dec 15.
- CEO Shane Schaffer base salary reduced 55% to $226,350; COO Laurie Myers reduced 50% to $212,000.
- Three directors (Gallagher, Givens, Medeiros) resigned.
- Clinical trial for CTx-1301 paused pending FDA guidance; expects ~$184k/month comp expense reduction.
- Company states no assurance of continued operations; needs significant capital; may file for bankruptcy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1862150/000149315223044970/0001493152-23-044970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1862150/000149315223044970/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer